Curing the Epilepsies 2026.
If we connected at the poster — welcome. Here's the deeper context the printed surface couldn't carry.
Komori Care is a privacy-first contactless multimodal nocturnal monitoring platform. The work you saw on the poster is the consumer-facing user-defined alert engine — the bigger story is a Multi-PI NIH STTR Phase I application in preparation with UVA Neurology and a forward path toward vEEG-anchored validation in the EMU.
Not a tracker. Not a wearable. Not a camera.
The premise: families and patients with SUDEP risk need nightly visibility that doesn't require wearing something or pointing a camera at the bed.
Not a tracker.
Trackers count steps and stages. Komori watches the night and reports what actually happened — movement events, position changes, environmental conditions, plus respiratory motion on the Pro sensor suite. The full night, not a daily score.
Not a wearable.
Nothing on the body. Komori sits at the bedside and senses through bedding via 60 GHz radar plus ambient WiFi channel-state-information sensing. Compliance is not a problem when there is nothing to wear.
Not a camera.
No video. No images. The on-device microphone only records audio features — sound-event classifications; raw audio is not kept anywhere unless the user explicitly asks for it. Thermal sensing is at body-position resolution only; cannot show faces or features. The thermal feed is fully encrypted and no images are stored — only derived metrics persist. Privacy is a structural property of the architecture, not a procedural commitment.
What the poster couldn't carry.
UVA Neurology partnership (in motion).
Multi-PI structure with Dr. Mark Quigg, MD (UVA Neurology, SUDEP enhanced multimodal monitoring). IRB 302295 amendment in motion to add Komori's contactless modalities to the existing protocol. Adult EMU phasing first, neonate / pediatric expansion path through Mark's lab in subsequent amendments.
NIH STTR Phase I.
Phase I application in preparation for the September 5, 2026 receipt date — focused on contactless modality reliability and multi-modal sensor architecture, with vEEG-anchored validation in the EMU as the forward path.
Multi-AI rule-discovery methodology.
Four LLM analyst pipelines across 68 public physiological corpora distilled to 695 top-markers → 649 retained rule records → 436 unique rule shapes → 91 build-now detector components organized into 4 multi-phase detector families. Manuscript in preparation for IEEE Signal Processing in Medicine and Biology (SPMB) 2026.
Active recruiting for sister-site investigators.
The STTR builds toward a multi-site validation study. Komori is actively recruiting EMU partners with vEEG + sleep-staging capability. If you run an EMU and are interested in evaluating contactless modalities under an existing or new IRB protocol — let's talk.
Take the materials with you.
A Novel Contactless Radar System with User-Defined Alerting
The poster presented at the NIH Curing the Epilepsies 2026 session — contactless 60 GHz radar, the user-defined alert engine, and the on-device privacy architecture.
View full resolution →
Komori Research Brief
A one-page overview of the platform, the UVA Neurology collaboration, and what we're looking for in research partners.
Download PDF →Why Komori exists.
I built Komori because my twin sons were born with Group B Strep and spent time in the NICU. My wife navigates a chronic sleep struggle. I have close friends with epilepsy.
Each one of them — and millions of families like ours — deserves the kind of nightly visibility that doesn't require strapping something to a body or pointing a camera at a bed.
Komori is the platform I wished existed when I was sitting in the NICU watching my sons on monitors I didn't understand, in a room without the privacy I wanted, with technology that couldn't tell me what I actually needed to know.
— Dōvy Paukstys, Founder
Built on real ground.
Discuss research collaboration.
If you're an EMU clinician, SUDEP-mechanism researcher, NINDS program officer, or epilepsy-research-adjacent industry partner — send an email and Dōvy will follow up within 48 hours.
hello@komoricare.comPrefer to read more first?
Visit komoricare.com →Komori is a wellness product and is not a medical device. It is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for clinical care, prescribed treatment, or any safety protocol recommended by a healthcare provider. Always follow your clinician's guidance.
Research-track collaborations referenced on this page (UVA IRB 302295 amendment, NIH STTR Phase I application in preparation) describe forward-looking research efforts and are not claims of current clearance, indication, or clinical performance.